UNSPSC 85523507: Supplement left hand vein with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left hand vein with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UH3KZ

UNSPSC 85523507 Supplement left hand vein with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity; the code's nominal scope—a specific surgical vascular procedure—does not align with the state and local opportunities currently tagged to it. The recent solicitations posted under this code cover occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent disability medical evaluations, surgical benefit carve-out programs, and youth detention medical services. None of these activities involve vascular tissue supplementation or the specific surgical intervention the code nominally describes. State and local procurement databases occasionally mismatch codes to solicitations, and this code appears to reflect that discrepancy rather than an active market segment.

The issuing bodies span county health systems (Santa Clara County), state transportation agencies (Washington State Department of Transportation), municipal retirement offices (City of Phoenix), county commissioners' offices (Collier County, Harris County), and city employee benefits programs (City of Long Beach), with posted opportunities concentrated in California, Arizona, Washington, and Florida during August and September 2026. However, given the code-to-opportunity mismatch, business development professionals should verify with procurement offices before pursuing work under this Commodity designation, as the tagging may reflect administrative error rather than genuine market demand for vascular supplementation procedures in state and local contracting.